Health By Justin Chen Scientists can track the spread of opioids in sewers. But do cities want to know what lies below?
First Opinion By Jeffrey L. Schnipper and Paul E. Sax Covid-19 test accuracy supplement: The math of Bayes’ Theorem
Politics By Megan Thielking In New Hampshire, Trump stands by universal health care in face of Cruz attacks
Pharmalot By Ed Silverman AbbVie may face fewer wrinkles after judge suggests a 10-year ban on a Botox rival
Don't Miss By Eric Boodman Night sweats, bloody cough — and a diagnosis that turned a doctor into an activist
By Erin Brodwin How Pinterest beat back vaccine misinformation — and what Facebook could learn from its approach
Pharma By Adam Feuerstein Merck chronic cough drug shows mixed results in late-stage clinical trials, raising questions about its future
By Rebecca Robbins, Casey Ross, and Erin Brodwin STAT Health Tech: Elon Musk’s secretive brain implants startup & Verily’s move into health insurance
By Nicholas Florko House Democrats are using the budget process to slam the Trump administration’s Covid-19 response
Pharmalot By Ed Silverman California supports an attorney’s unusual whistleblower lawsuit against ‘fraudulent’ patents
By Shraddha Chakradhar Last chance! Sign up for our STAT Plus event – “Gene therapy has arrived. What’s next?”
Biotech By Adam Feuerstein Karyopharm to seek expanded use of multiple myeloma drug following positive clinical trial
By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Drug industry infighting, the human side of genetic medicine, and a big year for the microbiome
Pharma By Jonathan Saltzman — Boston Globe Insys founder gets 5½ years in jail for his role in fentanyl prescription scheme
Biotech By Matthew Herper Cleveland Clinic’s Nissen denies any communication with FDA about Amarin’s Vascepa
Politics By Lev Facher Insurance, pharma figures spar over drug price legislation’s innovation impact
Pharmalot By Ed Silverman Pharmalittle: Four drug companies settle Ohio opioid suit; J&J recalls baby powder due to asbestos
Biotech By Jonathan Saltzman — Boston Globe UCB’s $2.5 billion purchase of Ra Pharma underscores immunology focus
Health By Matt Stout — Boston Globe Mass. declares public health emergency, orders 4-month ban on all vaping products
Biotech By Isabella Tran — Boston Globe Biotech industry aims to spark girls’ interests in science long before high school
Biotech By Damian Garde Myovant’s uterine fibroid drug meets goals in trial, setting up competition with AbbVie
Biotech By Matthew Herper Alector, with big ideas about treating dementia, presents a little bit of data